US Patent Issued to Spark Therapeutics on July 15 for "Relative potency assay for viral vector encoding isomerohydrolases" (California Inventor)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,359,239, issued on July 15, was assigned to Spark Therapeutics Inc. (Philadelphia).

"Relative potency assay for viral vector encoding isomerohydrolases" was invented by Linda Couto (Pleasanton, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods for assaying function and/or activity and/or potency of isomerohydrolase proteins are provided."

The patent was filed on April 28, 2017, under Application No. 16/096,673.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=12359239&OS=123...